Literature DB >> 1375511

Discordant regulation of human type I collagen genes by prostaglandin E2.

A Fine1, R Matsui, X Zhan, C F Poliks, B D Smith, R H Goldstein.   

Abstract

We examined the expression of type I collagen genes in prostaglandin E2 (PGE2)-treated human lung fibroblast cultures. Addition of PGE2 to fibroblast cultures inhibited alpha 1(I) mRNA levels by approx. 25% after 6 h and 60% after 24 h. Further studies showed that dibutyryl cAMP did not inhibit alpha 1(I) mRNA levels and that cycloheximide blocked the inhibitory effect of PGE2. In contrast, PGE2 treatment with or without cycloheximide did not affect alpha 2(I) mRNA levels. Moreover, in vitro translation of RNA derived from untreated and PGE2-treated cells yielded similar amounts of alpha 2(I) collagen peptides. Taken together, these results suggest that PGE2 induces a protein which inhibits alpha 1(I) transcription through distinct regulatory elements not under the control of cAMP and provide further evidence that the type I collagen genes can be discordantly regulated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375511     DOI: 10.1016/0167-4889(92)90167-a

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Induction of the myofibroblast phenotype following elastolytic injury to mouse lung.

Authors:  David C Rishikof; Edgar C Lucey; Ping-Ping Kuang; Gordon L Snider; Ronald H Goldstein
Journal:  Histochem Cell Biol       Date:  2005-11-19       Impact factor: 4.304

2.  Inhibition of protein translation as a novel mechanism for prostaglandin E2 regulation of cell functions.

Authors:  Katsuhide Okunishi; Angela J DeGraaf; Zbigniew Zasłona; Marc Peters-Golden
Journal:  FASEB J       Date:  2013-09-26       Impact factor: 5.191

3.  Variable prostaglandin E2 resistance in fibroblasts from patients with usual interstitial pneumonia.

Authors:  Steven K Huang; Scott H Wettlaufer; Cory M Hogaboam; Kevin R Flaherty; Fernando J Martinez; Jeffrey L Myers; Thomas V Colby; William D Travis; Galen B Toews; Marc Peters-Golden
Journal:  Am J Respir Crit Care Med       Date:  2007-10-04       Impact factor: 21.405

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.